Besides, the high expression of von Willebrand factor (VWF) has been confirmed in GBM plasma,[45] which not only serves as a diagnostic marker for glioma but also distinguishes BrM that can be considered a strong candidate biomarker. Here, VWF is linked to central nervous system cancer.